In Touch


Candace and Amelia Weir of Paradigm Capital Management explain the non-negotiable aspect of each of their investments, how they prospect for the “overlooked and underappreciated,” why they haven't done much trading in a volatile year, and why they think Genmark Diagnostics, Omnicell, Brooks Automation and Veeco Instruments offer upside value.

If you are a subscriber, log in to access the issue and bonus archive: